PMC:7696151 / 39511-39749
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1152","span":{"begin":121,"end":124},"obj":"Chemical"},{"id":"1160","span":{"begin":85,"end":105},"obj":"Disease"}],"attributes":[{"id":"A1152","pred":"tao:has_database_id","subj":"1152","obj":"MESH:D006886"},{"id":"A1160","pred":"tao:has_database_id","subj":"1160","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Initially, based on physiological pharmacokinetic models, Yao et al. recommended for SARS-CoV-2 infection a loading oral HCQ dose of 400 mg twice daily, followed by a maintenance dose of 200 mg administered twice daily for four days [50]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T258","span":{"begin":0,"end":238},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Initially, based on physiological pharmacokinetic models, Yao et al. recommended for SARS-CoV-2 infection a loading oral HCQ dose of 400 mg twice daily, followed by a maintenance dose of 200 mg administered twice daily for four days [50]."}